SCHEMBL22298065

SCHEMBL22298065

Cc1cc(C2(CCCN(C)C)OCc3cc(C#N)ccc32)ccc1F

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 15/20 0.80
SLC6A2 P23975 2/20 0.80
HTR2C P28335 2/20 0.80
ADRA1A P35348 2/20 0.80
HRH1 P35367 2/20 0.80
OPRM1 P35372 2/20 0.80
DRD3 P35462 2/20 0.80
HTR2B P41595 2/20 0.80
KCNH2 Q12809 2/20 0.80
NPC1 O15118 1/20 0.80
SLC22A1 O15245 1/20 0.80
ALDH1A1 P00352 1/20 0.80
CHRM2 P08172 1/20 0.80
HTR1A P08908 1/20 0.80
CHRM1 P11229 1/20 0.80
DRD1 P21728 1/20 0.80
ACHE P22303 1/20 0.80
HRH2 P25021 1/20 0.80
ADRA1D P25100 1/20 0.80
HTR2A P28223 1/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Citalopram SCHEMBL3858802 0.89 SLC6A4 (1.00) SLC6A4SLC6A2HTR2CADRA1AHRH1
(R)-Citalopram SCHEMBL13235283 0.89 SLC6A4 (1.00) SLC6A4SLC6A2HTR2CADRA1AHRH1
Citalopram SCHEMBL946 0.89 SLC6A4 (1.00) SLC6A4SLC6A2HTR2CADRA1AHRH1
Escitalopram SCHEMBL34948 0.89 SLC6A4 (1.00) SLC6A4SLC6A2HTR2CADRA1AHRH1
(R)-Citalopram SCHEMBL29414626 0.89 SLC6A4 (1.00) SLC6A4SLC6A2HTR2CADRA1AHRH1
Escitalopram SCHEMBL29358316 0.89 SLC6A4 (1.00) SLC6A4SLC6A2HTR2CADRA1AHRH1
Citalopram SCHEMBL29494157 0.89 SLC6A4 (1.00) SLC6A4SLC6A2HTR2CADRA1AHRH1
SCHEMBL145621 0.88 SLC6A4 (0.88) SLC6A4SLC6A2HTR2CADRA1AHRH1
SCHEMBL30130478 0.88 SLC6A4 (0.67) SLC6A4SLC6A2HTR2CADRA1AHRH1
SCHEMBL3407893 0.88 SLC6A4 (0.67) SLC6A4SLC6A2HTR2CADRA1AHRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3309142-B1 METHOD FOR PREPARING CITALOPRAM DIOL INTERMEDIATE ZHEJIANG HUAHAI PHARM CO LTD (CN) 2020-08-05 EP disclosed